Skip to content

    CORCEPT THERAPEUTICS (CORT) stock price & financials

    View CORT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+63.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $182.55M
    $181.89M
    $157.21M
    $194.43M
    $207.64M
    +13.7%
    $202.13M
    +11.1%
    $164.90M
    +4.9%
    $256.15M
    +31.7%
    Strengthening
    Operating Profit
    $46.60M
    $25.26M
    $3.42M
    $26.68M
    $10.22M
    -78.1%
    $4.49M
    -82.2%
    -$49.60M
    -1552.0%
    $41.30M
    +54.8%
    Weakening
    Net Profit
    $47.21M
    $30.75M
    $20.55M
    $35.15M
    $19.67M
    -58.3%
    $24.29M
    -21.0%
    -$31.76M
    -254.6%
    $42.99M
    +22.3%
    Weakening
    EPS
    $0.45
    $0.19
    $0.33
    $0.19
    -57.8%
    $-0.30
    -257.9%
    $0.40
    +21.2%
    Weakening
    Other Income
    $6.34M
    $6.70M
    $6.20M
    $5.02M
    $5.02M
    -20.8%
    $5.42M
    -19.1%
    $4.89M
    -21.2%
    $4.63M
    -7.7%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    $52.94M
    $31.96M
    $9.62M
    $31.69M
    $15.24M
    -71.2%
    $9.91M
    -69.0%
    -$44.72M
    -564.9%
    $45.93M
    +44.9%
    Weakening
    MarginsOPM
    25.5%
    13.9%
    2.2%
    13.7%
    4.9%
    -80.7%
    2.2%
    -84.0%
    -30.1%
    -1486.2%
    16.1%
    +17.5%
    Weakening
    Tax
    10.8%
    3.8%
    -113.6%
    -10.9%
    -29.0%
    -368.3%
    -145.1%
    -3918.2%
    29.0%
    6.4%
    Weakening
    ReturnsROIC
    10.3%
    6.7%
    4.5%
    7.7%
    4.3%
    -58.3%
    5.3%
    -21.0%
    -6.9%
    -254.6%
    9.4%
    +22.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$41.63M$31.27M$76.19M$77.62M$66.33M$135.55M$127.67M$120.50M$111.04M
    Short-Term Investments$165.13M$244.69M$364.51M$145.92M$365.34M$232.67M$255.67M$251.66M$197.16M
    Total Current Assets$236.82M$307.36M$478.50M$266.46M$499.25M$458.64M$471.60M$485.46M$439.68M
    Net PP&E$655.0K$4.50M$4.18M$1.52M$1.78M$315.0K$8.01M$6.47M$11.99M
    Goodwill
    Intangibles
    Total Assets$311.69M$412.31M$571.73M$423.76M$583.43M$621.52M$840.55M$836.65M$888.70M
    LiabilitiesTotal Current Liabilities$35.57M$38.84M$47.49M$47.54M$72.49M$104.50M$140.77M$166.09M$153.80M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$1.90M$501.0K$0$0$6.11M$5.02M$7.50M
    Total Liabilities$35.81M$41.13M$48.39M$47.95M$81.59M$114.81M$160.96M$188.85M$182.93M
    EquityCommon Stock & APIC$117.0K$120.0K$122.0K$127.0K$131.0K$133.0K$136.0K$140.0K$142.0K
    Retained Earnings-$117.74M-$23.55M$82.46M$194.97M$296.39M$402.53M$543.74M$643.39M$654.61M
    Total Equity$275.88M$371.18M$523.34M$375.81M$501.84M$506.70M$679.59M$647.80M$705.78M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$115.67M$136.12M$151.97M$167.89M$120.32M$126.68M$198.29M$142.00M$109.70M
    Cash from Investing-$90.77M-$117.83M-$119.26M$136.13M-$114.33M$90.91M-$177.60M$69.76M-$21.90M
    Cash from Financing-$14.34M-$28.64M$12.21M-$302.59M-$17.28M-$148.72M-$28.35M-$220.37M-$78.91M
    SummaryCapital Expenditure-$298.0K-$1.09M-$1.24M-$469.0K-$413.0K-$139.0K-$2.17M-$211.0K-$2.78M
    Free Cash Flow$115.37M$135.03M$150.73M$167.42M$119.91M$126.54M$196.12M$141.78M$106.92M
    FCF Margin45.9%44.1%42.6%45.7%29.8%26.2%29.1%18.6%12.9%

    Ratios